Renaissance BioScience Corp. is excited to announce the granting of a new patent for its proprietary yeast-based platform technology, which enables low-cost production and effective delivery of RNA. This patent, awarded by the Australian patent office, marks the second patent for this RNA technology intellectual property, following an earlier award from China. The Australian patent adds to the company's growing portfolio of issued and pending patents aimed at various end-use markets.

The most commercially developed application of Renaissance's yeast-based RNA production and delivery system is a range of RNAi-based biopesticide products offering a precise and targeted pest control method. These RNAi-based biopesticides are designed to be environmentally safer than conventional broad-spectrum chemical pesticides while maintaining comparable cost structures when produced at scale. Crucially, the technology integrates seamlessly with current farming practices and equipment.

With Australia recognized as one of the largest and most innovative agricultural economies globally, the timing of this patent issuance aligns perfectly with Renaissance’s ongoing commercial agricultural applications of this advanced technology.

Beyond its role as a safe, effective, and affordable insecticide for agricultural and other insect biocontrol applications, this RNA technology platform also shows significant promise in additional multi-billion-dollar market sectors, particularly in animal health and human medicine.

Renaissance’s yeast-based platform technology addresses critical challenges associated with RNA usage across various industries. While RNA serves as a powerful tool, its application has been limited due to high production costs and the inherent fragility of RNA molecules. The Renaissance RNA technology platform effectively overcomes these challenges, facilitating a broader application of RNA across multiple sectors.